Targeting immune checkpoints in malignant glioma

Malignant glioma is the most common and a highly aggressive cancer in the central nervous system (CNS). Cancer immunotherapy, strategies to boost the bodys anti-cancer immune responses instead of directly targeting tumor cells, recently achieved great success in treating several human solid tumors....

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xuhao, Zhu, Shan, Li, Tete, Liu, Yong-Jun, Chen, Wei, Chen, Jingtao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5351697/
https://www.ncbi.nlm.nih.gov/pubmed/27756892
http://dx.doi.org/10.18632/oncotarget.12702

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5351697/
https://www.ncbi.nlm.nih.gov/pubmed/27756892
http://dx.doi.org/10.18632/oncotarget.12702

Ejemplares similares